Dalil Hannani

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Sophie Viaud, Fabiana Saccheri, Grégoire Mignot et al. · Science · 2013 · 2K citations · Full text

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Cancer Immunosurveillance, Medicine, Immunology +8

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

Yuting Ma, Sandy Adjemian, Stephen R. Mattarollo et al. · Immunity · 2013 · 667 citations

Tumor Immunology, Cancer Immunosurveillance, Medicine +7

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

Takahiro Yamazaki, Dalil Hannani, Vichnou Poirier-Colame et al. · Cell Death and Differentiation · 2013 · 236 citations · Full text

Tumor Biology, Compensatory Therapy, Cancer Immunosurveillance +14

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

Dalil Hannani, Marie Vétizou, David Enot et al. · Cell Research · 2015 · 157 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, Soluble Cd25 +11